368 related articles for article (PubMed ID: 8423236)
1. Lovastatin inhibits proliferation of rat mesangial cells.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
[TBL] [Abstract][Full Text] [Related]
2. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
Miner Electrolyte Metab; 1993; 19(3):173-9. PubMed ID: 8232104
[TBL] [Abstract][Full Text] [Related]
3. [Inhibitory effects of lovastatin on the proliferation and cell cycle phase of cultured human glomerular mesangial cells in vitro].
Li H; Li XW; Duan L; Li CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):63-6. PubMed ID: 12905842
[TBL] [Abstract][Full Text] [Related]
4. The effect of lovastatin on proliferation of cultured rat mesangial and aortic smooth muscle cells.
Choi KH; Kang SW; Lee SW; Lee HY; Han DS; Kang BS
Yonsei Med J; 1995 Jul; 36(3):251-61. PubMed ID: 7660676
[TBL] [Abstract][Full Text] [Related]
5. Effects of lipids on the pathogenesis of progressive renal failure: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in the prevention of glomerulosclerosis.
Guijarro C; Keane WF
Miner Electrolyte Metab; 1996; 22(1-3):147-52. PubMed ID: 8676808
[TBL] [Abstract][Full Text] [Related]
6. Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin.
Massy ZA; Kim Y; Guijarro C; Kasiske BL; Keane WF; O'Donnell MP
Biochem Biophys Res Commun; 2000 Jan; 267(2):536-40. PubMed ID: 10631097
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis.
Maltese WA; Sheridan KM
J Cell Physiol; 1985 Dec; 125(3):540-58. PubMed ID: 3851809
[TBL] [Abstract][Full Text] [Related]
8. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
Cuthbert JA; Lipsky PE
Cancer Res; 1997 Aug; 57(16):3498-505. PubMed ID: 9270019
[TBL] [Abstract][Full Text] [Related]
9. Lovastatin inhibits lipopolysaccharide-induced NF-kappaB activation in human mesangial cells.
Guijarro C; Kim Y; Schoonover CM; Massy ZA; O'Donnell MP; Kasiske BL; Keane WF; Kashtan CE
Nephrol Dial Transplant; 1996 Jun; 11(6):990-6. PubMed ID: 8671958
[TBL] [Abstract][Full Text] [Related]
10. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
Choi JW; Jung SE
J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
[TBL] [Abstract][Full Text] [Related]
11. Effect of inhibition of cholesterol synthetic pathway on the activation of Ras and MAP kinase in mesangial cells.
Bassa BV; Roh DD; Vaziri ND; Kirschenbaum MA; Kamanna VS
Biochim Biophys Acta; 1999 Mar; 1449(2):137-49. PubMed ID: 10082972
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin inhibits the cellular signaling and proliferative action of arginine vasopressin in cultured rat glomerular mesangial cells.
Ishikawa S; Kawasumi M; Saito T
Endocrinology; 1995 May; 136(5):1954-61. PubMed ID: 7720643
[TBL] [Abstract][Full Text] [Related]
13. Requirement for mevalonate in the control of proliferation of human breast cancer cells.
Wejde J; Blegen H; Larsson O
Anticancer Res; 1992; 12(2):317-24. PubMed ID: 1580550
[TBL] [Abstract][Full Text] [Related]
14. Geranylgeraniol restores cell proliferation to lovastatin treated C6 glial cells.
Crick DC; Waechter CJ; Andres DA
SAAS Bull Biochem Biotechnol; 1996; 9():37-42. PubMed ID: 8652130
[TBL] [Abstract][Full Text] [Related]
15. Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome.
Frenkel J; Rijkers GT; Mandey SH; Buurman SW; Houten SM; Wanders RJ; Waterham HR; Kuis W
Arthritis Rheum; 2002 Oct; 46(10):2794-803. PubMed ID: 12384940
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of lovastatin on proliferation and expression of proinflammatory cytokines in cultured human glomerular mesangial cells.
Li H; Li X; Duan L; Li C
Chin Med J (Engl); 2003 Sep; 116(9):1366-9. PubMed ID: 14527367
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation.
Raiteri M; Arnaboldi L; McGeady P; Gelb MH; Verri D; Tagliabue C; Quarato P; Ferraboschi P; Santaniello E; Paoletti R; Fumagalli R; Corsini A
J Pharmacol Exp Ther; 1997 Jun; 281(3):1144-53. PubMed ID: 9190847
[TBL] [Abstract][Full Text] [Related]
18. Importance of geranylgeranyl pyrophosphate for mesangial cell DNA synthesis.
Massy ZA; Guijarro C; Oda H; Kasiske BL; Keane WF; O'Donnell MP
Kidney Int Suppl; 1999 Jul; 71():S80-3. PubMed ID: 10412744
[TBL] [Abstract][Full Text] [Related]
19. HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):99-110. PubMed ID: 9221829
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis.
Munro E; Patel M; Chan P; Betteridge L; Clunn G; Gallagher K; Hughes A; Schachter M; Wolfe J; Sever P
Eur J Clin Invest; 1994 Nov; 24(11):766-72. PubMed ID: 7890015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
